MCM
RGNX icon

McKinley Capital Management’s Regenxbio RGNX Stock Holding History

McKinley Capital Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-888
Closed -$51K – 269
2019
Q1 		$51K Buy
888
+303
+52% +$15K ﹤0.01% 231
2018
Q4 		$25K Sell
585
-650
-53% -$38.1K ﹤0.01% 276
2018
Q3 		$94K Sell
1,235
-112
-8% -$8.07K 0.01% 263
2018
Q2 		$96K Sell
1,347
-105
-7% -$5.01K 0.01% 268
2018
Q1 		$43K Sell
1,452
-40,269
-97% -$1.17M ﹤0.01% 309
2017
Q4 		$1.39M Buy
41,721
+29
+0.1% +$874 0.07% 197
2017
Q3 		$1.37M Buy
+41,692
New +$938K 0.06% 201

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $7.71B AUM 4.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
WM
WS Management Jacksonville, Florida $1.14B AUM 139.27% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

McKinley Capital Management's RGNX Position: Q2 2019 in Review

McKinley Capital Management sold out of Regenxbio (RGNX) in Q2 2019, closing a stake of 888 shares — an estimated $51K sold.

McKinley Capital Management first reported a position in RGNX in Q3 2017 and held it in 7 quarters. The position peaked at $1.39M in Q4 2017. 186 funds tracked by Wall St. Rank hold RGNX as of Q2 2019.

  • McKinley Capital Management reported no remaining Regenxbio position as of Q2 2019 after selling out during the quarter.
  • McKinley Capital Management sold 888 Regenxbio shares in Q2 2019, an estimated $51K.
  • McKinley Capital Management first reported a position in Regenxbio in Q3 2017 and held it in 7 quarters.
  • McKinley Capital Management's Regenxbio position peaked at $1.39M in Q4 2017.
  • 186 funds tracked by Wall St. Rank held Regenxbio as of Q2 2019.

Based on McKinley Capital Management's 13F filing for Q2 2019, filed 7 Aug 2019.